The common mitochondrial DNA deletion ΔmtDNA4977: Sheding new light to the concept of a tumor suppressor mutation

Medical Hypotheses

Volumn 61, Issue 1, 2003, Pages 60-63

  Dani, Sergio U ^a,b   Dani, Maria Angela C ^a   Simpson, Andrew J G ^c  

^a AADM Gene Ther Ctr and Genon Ltd   (Brazil)

^b Genon Ltd   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AGE; CARCINOGENESIS; GENE DELETION; GENE FUNCTION; GENE MUTATION; MALIGNANT TRANSFORMATION; MITOCHONDRIAL GENETICS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0038339472     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00105-1     Document Type: Review

References (29)

1. Cavalli L. R., Varella-Garcia M., Liang B. C. Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ 1997; 8: 1189-1198.
2. Israel B. A., Schaeffer W. I. Cytoplasmic suppression of malignancy. In Vitro Cell Dev Biol 1987; 23: 627-632.
3. Israel B. A., Schaeffer W. I. Cytoplasmic mediation of malignancy. In Vitro Cell Dev Biol 1988; 24: 487-497.
4. Hayashi J.-I., Takemitsu M., Nonaka I. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet 1992; 18: 123-129.
5. Wilkie D., Evans I. Mitochondria and the yeast cell surface: implication for carcinogenesis. Trends Biochem Sci 1982; 7: 147-151.
6. Soslau G., Fuhrer J. P., Nass M. M. K., Warren L. The effects of ethidium bromide on the membrane glycopeptides in control and virus transformed cells. J Biol Chem 1974; 249: 3014-3020.
7. Morais R., Zinkewich-Pootti K., Parent M., Wang H., Babai F., Zollinger M. Tumor forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res 1994; 54: 3889-3896.
8. Baggetto L. G. Role of mitochondria in carcinogenesis. Eur J Cancer 1993; 29A: 156-159.
9. Liang B. C., Hays L. Mitochondrial DNA copy number changes in human gliomas. Cancer Lett 1996; 105: 167-173.
10. Bianchi M. S., Bianchi N. O., Bailiet G. Mitochondrial DNA mutations in normal and tumor tissue from breast cancer patients. Cytogenet Cell Genet 1995; 71: 99-103.
11. Pederson P. L. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 1978; 22: 198-274.
12. Cortopassi G. A., Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990; 18: 6927-6933.
13. Cortopassi G. A., Shibata D., Soong N.-W., Arnheim N. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 1992; 89: 7370-7374.
14. Ikebe S.-I., Tanaka M., Ohno K., Sata W., Hattori K., Kondo T. et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun 1990; 170: 1044-1048.
15. Corral-Debrinski M., Horton T., Lott M. T., Shoffner J. M., Beal M. F., Wallace D. C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 1992; 2: 324-329.
16. Hamblet N. S., Castora F. J. Elevated levels of the Kearns-Sayre syndrome mitochondrial DNA deletion in temporal cortex of Alzheimer's patients. Mutat Res 1997; 379: 253-262.
17. Corral-Debrinski M., Horton T., Lott M. T., Shoffner J. M., McKee A. C., Beal M. F., Graham B. H., Wallace D. C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 1994; 23: 471-476.
18. Hattori K., Tanaka M., Sugiyama S., Obayashi T., Takayki I., Satake T. et al. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributory factor to presbycardia. Am Heart J 1991; 121: 1735-1742.
19. Gattermann N., Berneburg M., Heinisch J., Aul C., Schneider W. Detection of ageing-associated 5-kb common deletion of mitochondrial DNA in blood and bone marrow of hematologically normal adults. Absence of the deletion in clonal bone marrow disorders. Leukemia 1995; 9: 1704-1710.
20. Tallini G., Ladanyi M., Rosai J., Jhanwar S. C. Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet 1994; 66: 253-259.
21. Fukushima S., Honda K., Awane M., Yamamoto E., Takeda R., Kaneko I., Tanaka A., Morimoto T., Tanaka K., Yamaoka Y. The frequency of 4977 base pair deletion of mitochondrial DNA in various types of liver disease and in normal liver. Hepatology 1995; 21: 1547-1551.
22. 4977, a tumor suppressor mutation. Work presented at the Mitochondria Minisymposium, NIH - Bethesda MA, USA, 1998.
23. Alonso A., Martin P., Albarran C., Aguilera B., Garcia O., Guzman A., Oliva H., Sancho M. Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis 1997; 18: 682-685.
24. Burgart L. J., Zheng J., Shu Q., Strickler J. G., Shibata D. Somatic mitochondrial mutation in gastric cancer. Am J Pathol 1995; 147: 1105-1111.
25. Warburg O. On the origin of cancer cells. Science 1956; 123: 3191, 309-314.
26. Ausprunk D. H., Knigthon D. R., Folkman J. Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Am J Pathol 1975; 79: 597.
27. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79: 115-1164.
28. Knighton D., Ausprunk D., Tapper D., Folkman J. Avascular and vascular phase of tumor growth in the chick embryo. Br J Cancer 1977; 35: 347-356.
29. Kubota N., Hayashi J.-I., Inada T., Iwamura Y. Induction of a particular deletion in mitochondrial DNA by X-rays depends on the inherent radiosensitivity of the cells. Radiat Res 1997; 148: 395-398.